BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11008534)

  • 1. [Is the benefit of organized mass screening for cervix cancer and breast cancer in Norway scientifically justified?].
    Zahl PH
    Tidsskr Nor Laegeforen; 2000 Jun; 120(17):2002-5. PubMed ID: 11008534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
    Thoresen SO; Skare GB; Sandvin O
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Scientific criteria methods for estimating and evaluation of screening].
    Zahl PH
    Tidsskr Nor Laegeforen; 2003 Feb; 123(3):333-6. PubMed ID: 12640903
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
    Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence and mortality of uterine cervix cancer in Norway. When do we get organized nation-wide cytologic screening in Norway?].
    Magnus K; Langmark F
    Tidsskr Nor Laegeforen; 1990 May; 110(12):1557-9. PubMed ID: 2187277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different motives behind criticism of mass screening for cancer of the breast and cervix uteri].
    Thoresen SO
    Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2807-9. PubMed ID: 11107931
    [No Abstract]   [Full Text] [Related]  

  • 7. [Criticism of mass screening for breast cancer and cervix cancer].
    Zahl PH
    Tidsskr Nor Laegeforen; 2000 Nov; 120(29):3602. PubMed ID: 11188395
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for cancer].
    Bjørge T; Tropé CG; Engeland A
    Tidsskr Nor Laegeforen; 1999 Mar; 119(8):1129-36. PubMed ID: 10228417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simultaneous screening of cancers of the breast, cervix, colon and rectum. The Isère experience].
    Exbrayat C; Garnier A; Bolla M; Winckel P; Salicru B; Marron J; Faure H; Menegoz F; Billette de Villemeur A
    Bull Cancer; 1996 Aug; 83(8):641-8. PubMed ID: 8869044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [When will mammography screening reduce breast cancer mortality?].
    Strand BH; Zahl PH
    Tidsskr Nor Laegeforen; 2001 Aug; 121(20):2390-2. PubMed ID: 11603048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammography activity in Norway 1983 to 2008.
    Lynge E; Braaten T; Njor SH; Olsen AH; Kumle M; Waaseth M; Lund E
    Acta Oncol; 2011 Oct; 50(7):1062-7. PubMed ID: 21830995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cervical cancer after 10 years of nationally coordinated screening].
    Haldorsen T; Skare GB; Steen R; Thoresen SO
    Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer of the cervix uteri: analysis of the cost-benefit and efficacy of opportunistic screening versus organized screening].
    Castronovo V; Foidart JM; Boniver J
    Rev Med Liege; 1998 May; 53(5):305-7. PubMed ID: 9689888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Organised' cervical screening 45 years on: How consistent are organised screening practices?
    Williams JH; Carter SM; Rychetnik L
    Eur J Cancer; 2014 Nov; 50(17):3029-38. PubMed ID: 25282406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mass screening for cervical cancer. A one-year registration of cervical cytological tests].
    Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
    Tidsskr Nor Laegeforen; 1994 Jan; 114(3):341-5. PubMed ID: 8191435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for cancer. International knowledge and Danish practice].
    Lynge E
    Ugeskr Laeger; 2002 May; 164(22):2892-7. PubMed ID: 12082817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Register-based studies of cancer screening effects.
    Von Euler-Chelpin M; Lynge E; Rebolj M
    Scand J Public Health; 2011 Jul; 39(7 Suppl):158-64. PubMed ID: 21775376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When should we stop screening?
    Rich JS; Black WC
    Eff Clin Pract; 2000; 3(2):78-84. PubMed ID: 10915327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.